ADEWALE ADEFOWOJU: Open Payments
NPI 1114153186 · UNION, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,698 in 121 payments from 14 companies in 2025. Trend: 2023 $16,404 · 2024 $16,669 · 2025 $13,698
Speaker / faculty: $10,891Food & beverage: $2,356Consulting: $330Education: $121
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $7,361 |
| ABBVIE INC. | 29 | $4,720 |
| Alkermes, Inc. | 23 | $416 |
| Otsuka America Pharmaceutical, Inc. | 14 | $331 |
| E.R. Squibb & Sons, L.L.C. | 10 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $159 |
| Gilead Sciences, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 4 | $64 |
| Braeburn Inc. | 4 | $62 |
Products named: AUSTEDO XR, VRAYLAR, ARISTADA, COBENFY, REXULTI, CAPLYTA, ABILIFY MAINTENA, UZEDY.
Industry payments across NJ — which companies pay providers there.
